Press Releases

12th December 2016: Paras Biopharmaceuticals receives Quality Choice award from European Society for Quality Research, Switzerland
25th August 2016: Oulu-based Paras Biopharmaceuticals develops technology for Osteoporosis biosimilar drug & brings international investments. Expansion scheduled in Oulu.
24th November 2015: Paras Biopharmaceuticals forms partnership with Novozymes to embrace Veltis® technology for once-a-week Teriparatide Biobetter for Osteoporosis
28th April 2015: Paras Biopharmaceuticals Finland Oy Selected as First Finnish Company to Present at Cavendish Global Health Impact Forum
11th December 2014: Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan

To view award report, click on the link below

Award Report

*NEW* Photos of Award Ceremony and Banquet

Media Contact

Dr. Mark Jackson
Public Affairs

Company Presentation 2018

Company Presentation 2016

Company Presentation 2014

Company Presentation 2012

Meet Us At

Connect with us

Paras Biopharmaceuticals
Finland Oy

Kiviharjunlenkki 10, OULU,
FI-90220 Finland

P: +358 442709462

Dr Ashesh Kumar
P: +358 (0) 400207380

Dr Upendra Khurana
P:+358 (0) 449783160

Dr Mark Jackson
P:+358 (0) 442905993

Skype: Paras.Finland